Search results
Results from the WOW.Com Content Network
The American Journal of Alzheimer's Disease & Other Dementias is abstracted and indexed in, among other databases: SCOPUS, and the Social Sciences Citation Index. According to the Journal Citation Reports, its 2010 impact factor is 1.774, ranking it 104 out of 185 journals in the category 'Clinical Neurology'.
From Plan to Impact V: WHO Global action plan: The time to act is now [52] 2021 From Plan to Impact IV: Progress towards targets of the WHO Global action plan on dementia [53] 2020 From Plan to Impact III: Maintaining dementia as a priority in unprecedented times [54] 2019 From Plan to Impact II: The urgent need for action [55] 2018
The Journal of Alzheimer's Disease is a peer-reviewed medical journal published by IOS Press covering the etiology, pathogenesis, epidemiology, genetics, treatment, and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, hypotheses, ethics reviews, book reviews, and letters-to-the-editor ...
The Alzheimer's Impact Movement (AIM) is a separately incorporated 501(c)(4) advocacy affiliate of the Alzheimer's Association. AIM works to secure policies to overcome Alzheimer's and dementia, including increased investment in research, improved care and support, and development of approaches to reduce the risk of developing dementia.
Women are far more likely than men to suffer from Alzheimer’s, making up at least two-thirds of the 5.8 million Americans with it.
An estimated 60% to 70% of people with cognitive impairment or dementia have sleep disturbances, according to a scientific article published in the journal Seminars Neurology.
It's expected to help more dementia patients afford the new drugs. New Alzheimer's drugs will be covered by Medicare, if they are granted full FDA approval. ... About 6.7 million people over age ...
Increasing burden of dementia over time due to aging populations. [2] The prevalence of Alzheimer's disease and other dementias is significant in East Asian countries compared to the global average, which has 667 cases per 100,000 people. [2] Japan has the highest prevalence of AD in the world at 3,079 cases per 100,000 population. [2]